CI
AGN

Chartist Inc’s Allergan Inc AGN Stock Holding History

Chartist Inc’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,529
Closed -$365K – 37
2017
Q1 		$365K Sell
1,529
-33
-2% -$7.88K 0.18% 21
2016
Q4 		$328K Sell
1,562
-134
-8% -$28.1K 0.17% 22
2016
Q3 		$391K Sell
1,696
-148
-8% -$34.1K 0.2% 20
2016
Q2 		$426K Buy
+1,844
New +$426K 0.23% 19
2015
Q4 		$600K Buy
+1,921
New +$600K 0.3% 18
2015
Q3 		– Sell
-15,248
Closed -$4.69M – 39
2015
Q2 		$4.69M Buy
+15,248
New +$4.69M 2.26% 16

Other funds holding AGN

FIM
Frontier Investment Management Dallas, Texas $1.62B AUM 1.86% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
MA
Marshwinds Advisory St Simons Island, Georgia $187M AUM 1.79% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $552M AUM 26% 1-Year Est. Return

Chartist Inc's AGN Position: Q2 2017 in Review

Chartist Inc sold out of Allergan Inc (AGN) in Q2 2017, closing a stake of 1,529 shares — an estimated $365K sold.

Chartist Inc first reported a position in AGN in Q2 2015 and held it in 6 quarters. The position peaked at $4.69M in Q2 2015. 13 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Chartist Inc reported no remaining Allergan Inc position as of Q2 2017 after selling out during the quarter.
  • Chartist Inc sold 1,529 Allergan Inc shares in Q2 2017, an estimated $365K.
  • Chartist Inc first reported a position in Allergan Inc in Q2 2015 and held it in 6 quarters.
  • Chartist Inc's Allergan Inc position peaked at $4.69M in Q2 2015.
  • 13 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2017.

Based on Chartist Inc's 13F filing for Q2 2017, filed 15 Aug 2017.